Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Pfizer said in October that it is considering ... Walmsley said that “it would be weird” if GSK does not look at buying the business. But GSK is only looking at the business Walmsley said ...

Leading MNCs include Abbott (#1st Rank), GSK (#4th Rank) and Pfizer (includes Wyeth, #8th Rank) finding their presence among the Top 10 players in the domestic market. This also includes Daichii ...

Investors would want to prepare for rotating out of the seven - Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), Nvidia (NVDA), Meta (META), and Tesla (TSLA). In exchange, they ...

A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Cura Health, a leading provider in Kuwait's pharmaceutical and healthcare sector, today hosted a wellness event for its ...